​

Amgen (AMGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AMGN Stock Forecast

Amgen (AMGN) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $394.58, with a high of $460.00 and a low of $230.00. This represents a -3.82% decline from the last price of $410.24.

$200 $260 $320 $380 $440 $500 High: $460 Avg: $394.58 Low: $230 Last Closed Price: $410.24

AMGN Stock Rating

Amgen stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 22 Buy (53.66%), 16 Hold (39.02%), 3 Sell (7.32%), and 0 Strong Sell (0.00%).

Buy
Total 41 3 16 22 0 Strong Sell Sell Hold Buy Strong Buy

AMGN Price Target Upside V Benchmarks

TypeNameUpside
StockAmgen-3.82%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks7.92%

Price Target Trends

1M3M12M
# Anlaysts32252
Avg Price Target$425.00$392.68$367.67
Last Closing Price$410.24$410.24$410.24
Upside/Downside3.60%-4.28%-10.38%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26410162234
Aug, 26410172134
Jul, 26410172134
Jun, 26410182135
May, 2649192135
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 23, 2026Akash TewariJefferies$410.00$410.24-0.06%-0.06%
Sep 17, 2026Michael YeeUBS$430.00$378.4213.63%4.82%
Sep 04, 2026Mohit BansalWells Fargo$435.00$444.12-2.05%6.04%
Aug 20, 2026David AmsellemPiper Sandler$457.00$442.363.31%11.40%
Aug 19, 2026Morgan Stanley$362.00$440.28-17.78%-11.76%
Aug 19, 2026Argus Research$460.00$439.954.56%12.13%
Aug 18, 2026Cantor Fitzgerald$400.00$419.38-4.62%-2.50%
Aug 18, 2026Mizuho Securities$352.00$419.38-16.07%-14.20%
Aug 14, 2026Emily FieldBarclays$380.00$417.84-9.06%-7.37%
Aug 10, 2026Vamil DivanGuggenheim$388.00$410.95-5.58%-5.42%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 23, 2026JefferiesHoldHoldhold
Sep 23, 2026OppenheimerOutperformOutperformhold
Sep 17, 2026UBSBuyBuyhold
Sep 10, 2026HSBCBuyHolddowngrade
Sep 08, 2026BMO CapitalOutperformMarket Performdowngrade
Sep 04, 2026Wells FargoPositivePositivehold
Aug 20, 2026Piper SandlerOverweightOverweighthold
Aug 19, 2026Morgan StanleyOverweightOverweighthold
Aug 18, 2026Cantor FitzgeraldNeutralNeutralhold
Aug 10, 2026GuggenheimNeutralNeutralhold

Financial Forecast

EPS Forecast

$5 $11 $17 $23 $29 $35 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.34$12.18$12.56$7.62$14.33---
Avg Forecast$16.82$17.68$18.56$19.59$21.01$21.45$22.22$22.74
High Forecast$17.52$18.41$18.98$19.86$22.39$30.68$31.07$23.91
Low Forecast$16.19$16.80$18.23$19.25$19.62$10.68$16.86$21.04
Surprise %-38.53%-31.11%-32.33%-61.10%-31.79%---

Revenue Forecast

$25B $28B $31B $34B $37B $40B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$25.98B$26.32B$28.19B$33.42B$36.75B---
Avg Forecast$26.00B$26.17B$28.12B$33.20B$34.61B$35.07B$35.60B$36.33B
High Forecast$26.84B$27.00B$28.29B$33.48B$35.96B$35.08B$35.66B$37.75B
Low Forecast$25.25B$25.17B$27.97B$32.91B$32.45B$35.06B$35.55B$34.23B
Surprise %-0.09%0.58%0.26%0.68%6.18%---

Net Income Forecast

$0 $4B $8B $12B $16B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.89B$6.55B$6.72B$4.09B$7.71B---
Avg Forecast$5.71B$6.49B$6.72B$10.52B$11.30B$7.13B$12.89B$12.24B
High Forecast$6.85B$7.79B$8.06B$10.68B$12.05B$16.50B$16.71B$12.86B
Low Forecast$4.56B$5.19B$5.37B$10.36B$10.56B$5.74B$9.07B$11.32B
Surprise %3.29%0.90%--61.12%-31.77%---

AMGN Forecast FAQ

Is Amgen stock a buy?

Amgen stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 22 Buy, 16 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Amgen is a favorable investment for most analysts.

What is Amgen's price target?

Amgen's price target, set by 41 Wall Street analysts, averages $394.58 over the next 12 months. The price target range spans from $230 at the low end to $460 at the high end, suggesting a potential -3.82% change from the previous closing price of $410.24.

How does Amgen stock forecast compare to its benchmarks?

Amgen's stock forecast shows a -3.82% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the drug manufacturers - general stocks industry (7.92%).

What is the breakdown of analyst ratings for Amgen over the past three months?

  • September 2026: 11.76% Strong Buy, 29.41% Buy, 47.06% Hold, 5.88% Sell, 5.88% Strong Sell.
  • August 2026: 11.76% Strong Buy, 29.41% Buy, 50.00% Hold, 5.88% Sell, 2.94% Strong Sell.
  • July 2026: 11.76% Strong Buy, 29.41% Buy, 50.00% Hold, 5.88% Sell, 2.94% Strong Sell.

What is Amgen’s EPS forecast?

Amgen's average annual EPS forecast for its fiscal year ending in December 2026 is $21.45, marking a 49.69% increase from the reported $14.33 in 2025. Estimates for the following years are $22.22 in 2027, and $22.74 in 2028.

What is Amgen’s revenue forecast?

Amgen's average annual revenue forecast for its fiscal year ending in December 2026 is $35.07B, reflecting a -4.57% decrease from the reported $36.75B in 2025. The forecast for 2027 is $35.6B, and $36.33B for 2028.

What is Amgen’s net income forecast?

Amgen's net income forecast for the fiscal year ending in December 2026 stands at $7.13B, representing a -7.56% decrease from the reported $7.71B in 2025. Projections indicate $12.89B in 2027, and $12.24B in 2028.